Many holdings or asset management companies try to add as many healthcare-based subsidiaries as they can due to a sharp increase in rare diseases and the COVID-19 crisis as well.
Performant Financial (NASDAQ: PFMT) has been dealing with financial services like aiding students with recovering from educational loans but now it is ready to dedicate itself to improve the health of rare diseased ones.
Entering the healthcare industry will surely suck up at least a couple of millions USD. Let’s see what Performant Financial will offer to the widely diversified market. Perhaps, biotech will be the first on the list to consider for the company to analyze which drug, vaccine, or therapeutics to research and development.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.